Gene · 406909
Papers2,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular Vesicles as Biomarkers and Non-Surgical Therapeutics in Cardiovascular Diseases. | J Clin Med | 2026 | 41753224 | PubTator, text mining | PubMed |
| RNA-Based Biomarkers for Diagnostic Discrimination of Ischemic and Hemorrhagic Stroke: A Systematic Review. | J Clin Med | 2026 | 41753079 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Based Biomarkers in Spinal Cord Injury: A State-of-the-Art Review on Diagnostic and Prognostic Advances. | Int J Mol Sci | 2026 | 41752215 | PubTator, text mining | PubMed |
| MicroRNA as Potential Biomarkers and Their Pathogenesis in Multiple System Atrophy. | Int J Mol Sci | 2026 | 41752011 | PubTator, text mining | PubMed |
| The Mystery of the Hidden Trace: Emerging Genetic Approaches to Improve Body Fluid Identification. | Genes (Basel) | 2026 | 41751530 | PubTator, text mining | PubMed |
| Mitochondria-Associated MicroRNAs: Emerging Roles in the Pathogenesis of Parkinson's Disease. | Biomedicines | 2026 | 41751212 | PubTator, text mining | PubMed |
| ELABELA: A Potential Therapeutic Target for Ischemia-Reperfusion Injury. | Biomolecules | 2026 | 41750369 | PubTator, text mining | PubMed |
| Long non-coding RNAs in the exosomal network: dual roles and clinical implications in cancer. | Anim Cells Syst (Seoul) | 2026 | 41737608 | PubTator, text mining | PubMed |
| Independent validation of circulating microRNAs as biomarkers in a case-control study of adolescents with type 1 diabetes for more than 8 years. | PLoS One | 2026 | 41729882 | PubTator, text mining | PubMed |
| Colorectal cancer-derived extracellular vesicles: at the crossroads of the tumor microenvironment and gut microbiota. | Front Immunol | 2026 | 41727493 | PubTator, text mining | PubMed |
| Bioreactor expansion of human neural progenitor cells for exosome scalable production and miRNA-engineering. | J Biol Eng | 2026 | 41715202 | PubTator, text mining | PubMed |
| [Retracted] miR‑124‑3p inhibits the viability and motility of glioblastoma multiforme by targeting RhoG. | Int J Mol Med | 2026 | 41614420 | PubTator, text mining | PubMed |
| Research progress on the effects of macrophage‑derived exosomes on muscle factors IGF‑1 and FGF‑2 mediating musculoskeletal crosstalk molecular signaling pathway on bone metabolism (Review). | Int J Mol Med | 2026 | 41574692 | PubTator, text mining | PubMed |
| The Role of microRNAs as Potential Biomarkers in Diffuse Large B-Cell Lymphoma. | Noncoding RNA | 2026 | 41562708 | PubTator, text mining | PubMed |
| Comprehensive analysis of mRNA-microRNA-lncRNA expression profiles in post-traumatic elbow heterotopic ossification using RNA sequencing and experimental validation. | Ann Med | 2026 | 41530916 | PubTator, text mining | PubMed |
| Recent advances in the application of engineered extracellular vesicles from mesenchymal stem cells for traumatic central nervous system. | Eur J Pharmacol | 2026 | 41520759 | PubTator, text mining | PubMed |
| MicroRNAs as neuro-prognostic biomarkers after cardiac arrest: a systematic review. | Cardiovasc Res | 2026 | 41481796 | PubTator, text mining | PubMed |
| MicroRNA-124-3p suppresses lung cancer by targeting ITGB1/PI3K/p-AKT signal transduction pathway. | Exp Cell Res | 2026 | 41349760 | PubTator, text mining | PubMed |
| Aberrant MicroRNA-124 expression and methylation in the dorsolateral prefrontal cortex of depressed subjects. | J Psychiatr Res | 2026 | 41273925 | PubTator, text mining | PubMed |
| H2 as a potential redox homeostasis modulator: a review of mechanisms targeting key elements of cardiovascular pathogenesis-related pathways. | Mol Cell Biochem | 2026 | 41254431 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406909/papers?page=3